A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections-Reference-Cited by-同舟云学术

A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections

Published:2022-10 Issue: Volume:123 Page:157-165
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Sun Yihong^ORCID,Fan Jia,Chen Gang,Chen Xiaofei,Du Xiaoling,Wang Ye,Wang Hui,Sun Fang,Johnson Matthew G.,Bensaci Mekki,Huntington Jennifer A.,Bruno Christopher J.

Funder

Merck Sharp and Dohme

Merck & Co Inc

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis;Cassini;Lancet Infect Dis,2019

2. Antibiotic resistance threats in the United States. Atlanta: United States Department of Health and Human Services;Centers for Disease Control and Prevention,2019

3. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial;Chen;BMC Infect Dis,2010

4. Performance standards for antimicrobial susceptibility testing,2018

5. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs;Cosgrove;Clin Infect Dis,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence;Future Microbiology;2024-01-22

2. Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials;International Journal of Antimicrobial Agents;2023-08

3. Global evaluation of the antibacterial activity of Ceftolozane/Tazobactam against ESBLs-producing Escherichia coli and Klebsiella pneumoniae: a systematic review and meta-analysis;Therapeutic Advances in Infectious Disease;2023-01